Skip to content

Evolus EOLS Change in AR

Change in AR at other companies

AbbVie logo
AbbVieABBV
-$87M-106%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's change in AR?
Evolus (EOLS) reported change in AR of -$2.15M in Q1 2026.
How has Evolus's change in AR changed year-over-year?
Evolus's change in AR decreased by 361.7% year-over-year, from $823K to -$2.15M.
What is the long-term trend for Evolus's change in AR?
Over 4 years (2021 to 2025), Evolus's change in AR has grown at a 19.9% compound annual growth rate (CAGR), from $5.57M to $11.51M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.